Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
baseclick
Neuried, Bavaria, Germany
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
baseclick develops and commercializes click chemistry-based nucleic acid labeling and modification technologies used as research tools, diagnostics tools, and in preclinical development of RNA-based drugs and vaccines; it does not have disclosed clinical-stage therapeutic programs.[1][5]
- Modalities
- RNA therapymRNA-based drugsSynthetic oligonucleotideDNA vaccineVaccineSmall molecule
- Industry
- Molecular Diagnostics
02
Partnerships
Multiple undisclosed licensees of baseclick’s click chemistry nucleic acid modification technology for diagnostics, therapeutics, and vaccines (out‑licensing to numerous leading companies worldwide).
Beyond the preview
Go deeper on baseclick.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on baseclick.